Table 1.
Patient Blood Test Results After CCCR-NK92 Cell Therapy.
| Date | LDH (U/l) (109–245 U/l) | ALT (U/l) (7–40 U/l) | AST (U/l) (13–35 U/l) | FBG (mg/dl) (200–400 mg/dl) | D-D E-(μg/ml) (0–l μg/ml) | PLT (109/l) (125–350 × 109/l) | WBC (109/l) (3.5–9.5 × 109/l) |
|---|---|---|---|---|---|---|---|
| 2018/12/25 | 407 | 8 | 13 | 426 | 11.1 | 306 | 6.6 |
| 2019/01/03 | 1155 | — | — | 308 | 27 | 122 | 3.9 |
| 2019/01/05 | 321 | 82 | 95 | 97.9 | 43.7 | 118 | 6 |
| 2019/01/07 | 287 | 124 | 254 | 53.8 | 3.3 | 78 | 8.2 |
| 2019/01/11 | 241 | 59 | 53 | 122.l | 3 | 314 | 7.6 |
ALT: alanine aminotransferase; AST: aspartate aminotransferase; CCCR: chimeric costimulatory converting receptor; D-D: D-Dimer; FBG: fibrinogen; LDH: lactate dehydrogenase; PLT: platelets; WBC: white blood cells.